Dr Iris Depaz has over twenty years of experience in the pharmaceutical industry and scientific research. Iris obtained her PhD in Biomedical Sciences at the University of Queensland, Australia where she also conducted postdoctoral research and was an Associate Lecturer. She joined industry in 2007 and has worked in a variety of medical and R&D roles at local, regional and global levels in two global pharmaceutical companies including Medical Lead for the MMR and Varicella vaccine franchise for GSK based in Belgium and Head of Global Medical Effectiveness at Sanofi Vaccines based in France. Iris completed her EMBA with Honors at the IMD Business School in Lausanne Switzerland in 2020.
Currently, Iris is the Country Medical Lead and Vaccines Head of Medical for Sanofi ANZ. In 2023 she was appointed Managing Director of the Sanofi Global Translational Science Hub based in Brisbane. Her focus is on fostering scientific collaborations, elevating scientific communication, and establishing strategic partnerships to optimize vaccines and drug development, access and uptake. She has also led several digital health projects utilizing Natural Language Processing (AI), data analytics, blockchain technology and omnichannel solutions. Iris is also passionate about patient empowerment and improving health outcomes.